Stream Co.,Ltd. (TYO:3071)
111.00
-1.00 (-0.89%)
Aug 4, 2025, 3:30 PM JST
Verve Therapeutics Balance Sheet
Financials in millions JPY. Fiscal year is February - January.
Millions JPY. Fiscal year is Feb - Jan.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2021 |
---|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 30, 2025 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 | Jan '21 Jan 31, 2021 | 2017 - 2021 |
Cash & Equivalents | 896 | 895 | 649 | 1,133 | 1,792 | 1,394 | Upgrade |
Cash & Short-Term Investments | 896 | 895 | 649 | 1,133 | 1,792 | 1,394 | Upgrade |
Cash Growth | -3.76% | 37.90% | -42.72% | -36.78% | 28.55% | 110.89% | Upgrade |
Receivables | 1,687 | 1,699 | 1,516 | 1,486 | 1,908 | 1,319 | Upgrade |
Inventory | 2,970 | 2,613 | 2,865 | 2,703 | 2,819 | 2,316 | Upgrade |
Other Current Assets | 181 | 144 | 127 | 137 | 145 | 113 | Upgrade |
Total Current Assets | 5,734 | 5,351 | 5,157 | 5,459 | 6,664 | 5,142 | Upgrade |
Property, Plant & Equipment | 176 | 173 | 199 | 146 | 166 | 152 | Upgrade |
Long-Term Investments | 436 | 156 | 338 | 386 | 378 | 379 | Upgrade |
Other Intangible Assets | 362 | 360 | 348 | 346 | 363 | 320 | Upgrade |
Long-Term Deferred Tax Assets | - | 26 | 28 | 22 | 68 | 78 | Upgrade |
Other Long-Term Assets | 1 | 2 | 2 | 1 | 2 | 1 | Upgrade |
Total Assets | 6,709 | 6,305 | 6,203 | 6,360 | 7,641 | 6,072 | Upgrade |
Accounts Payable | 2,536 | 1,652 | 1,260 | 1,717 | 2,533 | 1,359 | Upgrade |
Accrued Expenses | 11 | 4 | 4 | 4 | 4 | 4 | Upgrade |
Short-Term Debt | 320 | 733 | 1,000 | 400 | 865 | 923 | Upgrade |
Current Portion of Long-Term Debt | 22 | 36 | 71 | 71 | 71 | 55 | Upgrade |
Current Income Taxes Payable | 600 | 698 | 587 | 794 | 772 | 785 | Upgrade |
Other Current Liabilities | 135 | 122 | 119 | 128 | 190 | 144 | Upgrade |
Total Current Liabilities | 3,624 | 3,245 | 3,041 | 3,114 | 4,435 | 3,270 | Upgrade |
Long-Term Debt | 69 | 73 | 109 | 181 | 253 | 325 | Upgrade |
Long-Term Deferred Tax Liabilities | - | - | 1 | - | - | - | Upgrade |
Other Long-Term Liabilities | 83 | 75 | 65 | 68 | 68 | 111 | Upgrade |
Total Liabilities | 3,776 | 3,393 | 3,216 | 3,363 | 4,756 | 3,706 | Upgrade |
Common Stock | 924 | 924 | 924 | 924 | 924 | 924 | Upgrade |
Additional Paid-In Capital | 885 | 885 | 885 | 888 | 876 | 876 | Upgrade |
Retained Earnings | 1,195 | 1,175 | 1,254 | 1,306 | 1,169 | 650 | Upgrade |
Treasury Stock | -109 | -109 | -109 | -152 | -152 | -152 | Upgrade |
Comprehensive Income & Other | 19 | 17 | 7 | - | 1 | 1 | Upgrade |
Total Common Equity | 2,914 | 2,892 | 2,961 | 2,966 | 2,818 | 2,299 | Upgrade |
Minority Interest | 19 | 20 | 26 | 31 | 67 | 67 | Upgrade |
Shareholders' Equity | 2,933 | 2,912 | 2,987 | 2,997 | 2,885 | 2,366 | Upgrade |
Total Liabilities & Equity | 6,709 | 6,305 | 6,203 | 6,360 | 7,641 | 6,072 | Upgrade |
Total Debt | 411 | 842 | 1,180 | 652 | 1,189 | 1,303 | Upgrade |
Net Cash (Debt) | 485 | 53 | -531 | 481 | 603 | 91 | Upgrade |
Net Cash Growth | -14.76% | - | - | -20.23% | 562.64% | - | Upgrade |
Net Cash Per Share | 17.55 | 1.92 | -19.29 | 17.63 | 22.10 | 3.33 | Upgrade |
Filing Date Shares Outstanding | 27.64 | 27.64 | 27.64 | 27.29 | 27.29 | 27.29 | Upgrade |
Total Common Shares Outstanding | 27.64 | 27.64 | 27.64 | 27.29 | 27.29 | 27.29 | Upgrade |
Working Capital | 2,110 | 2,106 | 2,116 | 2,345 | 2,229 | 1,872 | Upgrade |
Book Value Per Share | 105.44 | 104.64 | 107.14 | 108.69 | 103.27 | 84.25 | Upgrade |
Tangible Book Value | 2,552 | 2,532 | 2,613 | 2,620 | 2,455 | 1,979 | Upgrade |
Tangible Book Value Per Share | 92.34 | 91.62 | 94.55 | 96.01 | 89.96 | 72.52 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.